Academic Journal
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
| العنوان: | Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease |
|---|---|
| المؤلفون: | Kumar, Amit, Pintus, Francesca, Di Petrillo, Amalia, Medda, Rosaria, Caria, Paola, Matos, Maria João, Viña, Dolores, Pieroni, Enrico, Delogu, Francesco, Era, Benedetta, Delogu, Giovanna L., Fais, Antonella |
| المصدر: | Scientific Reports ; volume 8, issue 1 ; ISSN 2045-2322 |
| بيانات النشر: | Springer Science and Business Media LLC |
| سنة النشر: | 2018 |
| الوصف: | Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia and is affecting nearly 44 million people worldwide. AD is characterized by a progressive decline in acetylcholine levels in the cholinergic systems, which results in severe memory loss and cognitive impairments. Expression levels and activity of butyrylcholinesterase (BChE) enzyme has been noted to increase significantly in the late stages of AD, thus making it a viable drug target. A series of hydroxylated 2-phenylbenzofurans compounds were designed, synthesized and their inhibitory activities toward acetylcholinesterase (AChE) and BChE enzymes were evaluated. Two compounds ( 15 and 17 ) displayed higher inhibitory activity towards BChE with IC 50 values of 6.23 μM and 3.57 μM, and a good antioxidant activity with EC 50 values 14.9 μM and 16.7 μM, respectively. The same compounds further exhibited selective inhibitory activity against BChE over AChE. Computational studies were used to compare protein-binding pockets and evaluate the interaction fingerprints of the compound. Molecular simulations showed a conserved protein residue interaction network between the compounds, resulting in similar interaction energy values. Thus, combination of biochemical and computational approaches could represent rational guidelines for further structural modification of these hydroxy-benzofuran derivatives as future drugs for treatment of AD. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1038/s41598-018-22747-2 |
| الاتاحة: | http://dx.doi.org/10.1038/s41598-018-22747-2 https://www.nature.com/articles/s41598-018-22747-2.pdf https://www.nature.com/articles/s41598-018-22747-2 |
| Rights: | https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0 |
| رقم الانضمام: | edsbas.23A571E8 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s41598-018-22747-2 |
|---|